Your browser doesn't support javascript.
loading
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2: Subgroup Analysis of the Randomized CREDENCE Trial.
Bakris, George; Oshima, Megumi; Mahaffey, Kenneth W; Agarwal, Rajiv; Cannon, Christopher P; Capuano, George; Charytan, David M; de Zeeuw, Dick; Edwards, Robert; Greene, Tom; Heerspink, Hiddo J L; Levin, Adeera; Neal, Bruce; Oh, Richard; Pollock, Carol; Rosenthal, Norman; Wheeler, David C; Zhang, Hong; Zinman, Bernard; Jardine, Meg J; Perkovic, Vlado.
Afiliação
  • Bakris G; Department of Medicine, University of Chicago Medicine, Chicago, Illinois.
  • Oshima M; The George Institute for Global Health, University of New South Wales Sydney, Sydney, Australia.
  • Mahaffey KW; Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
  • Agarwal R; Department of Medicine, Stanford Center for Clinical Research, Stanford University School of Medicine, Stanford, California.
  • Cannon CP; Indiana University School of Medicine and Veterans Affairs Medical Center, Indianapolis, Indiana.
  • Capuano G; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
  • Charytan DM; Janssen Research & Development, LLC, Raritan, New Jersey.
  • de Zeeuw D; Nephrology Division, New York University School of Medicine and New York University Langone Medical Center, New York, New York.
  • Edwards R; Baim Institute for Clinical Research, Boston, Massachusetts.
  • Greene T; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Heerspink HJL; Janssen Research & Development, LLC, Raritan, New Jersey.
  • Levin A; Division of Biostatistics, Department of Population Health Sciences, University of Utah, Salt Lake City, Utah.
  • Neal B; The George Institute for Global Health, University of New South Wales Sydney, Sydney, Australia.
  • Oh R; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Pollock C; Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Rosenthal N; The George Institute for Global Health, University of New South Wales Sydney, Sydney, Australia.
  • Wheeler DC; Charles Perkins Centre, University of Sydney, Sydney, Australia.
  • Zhang H; Imperial College London, London, United Kingdom.
  • Zinman B; Janssen Research & Development, LLC, Raritan, New Jersey.
  • Jardine MJ; Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
  • Perkovic V; Janssen Research & Development, LLC, Raritan, New Jersey.
Clin J Am Soc Nephrol ; 15(12): 1705-1714, 2020 12 07.
Article em En | MEDLINE | ID: mdl-33214158

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Injúria Renal Aguda / Canagliflozina / Inibidores do Transportador 2 de Sódio-Glicose / Taxa de Filtração Glomerular / Rim Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin J Am Soc Nephrol Assunto da revista: NEFROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Injúria Renal Aguda / Canagliflozina / Inibidores do Transportador 2 de Sódio-Glicose / Taxa de Filtração Glomerular / Rim Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin J Am Soc Nephrol Assunto da revista: NEFROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos